Novel Proteins Regulated by mTOR in Subependymal Giant Cell Astrocytomas of Patients with Tuberous Sclerosis Complex and New Therapeutic ImplicationsMagdalena E. Tyburczy, Bożena Kamińska|American Journal Of Pathology|2010Cited by 83
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileKrinio Giannikou, David J. Kwiatkowski, Zachary Zhu et al.|Modern Pathology|2020Cited by 28
A genome-wide association study implicates<i>NR2F2</i>in lymphangioleiomyomatosis pathogenesisWonji Kim, David J. Kwiatkowski, John R. Dreier et al.|European Respiratory Journal|2019Cited by 22
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J. Kwiatkowski, Sabina Signoretti, Jean‐Christophe Pignon et al.|Unknown|2023Cited by 0
Table S1 from Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J. Kwiatkowski, Sabina Signoretti, Toni K. Choueiri et al.|Unknown|2023Cited by 0